Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      USFDA okays Xeris Pharma glucagon pen Gvoke to treat low blood sugar

      USFDA okays Xeris Pharma glucagon pen Gvoke to treat low blood sugar

      Medical Dialogues Bureau13 Sept 2019 9:00 AM IST
      Xeris Pharma's Gvoke, a glucagon pen is a pre-filled device with a liquid stable form of glucagon.U.S: The U.S. Food and Drug Administration has...
      Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

      Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

      Medical Dialogues Bureau12 Sept 2019 5:41 PM IST
      The Ankleshwar site is Sanofi India's oldest manufacturing facility where brands like Combiflam, Allegra and Amaryl are made. The production of these...
      Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

      Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

      Medical Dialogues Bureau12 Sept 2019 10:00 AM IST
      The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic...
      Alkem Labs gets EIR from USFDA for St.Louis facility

      Alkem Labs gets EIR from USFDA for St.Louis facility

      Medical Dialogues Bureau12 Sept 2019 9:30 AM IST
      "In furtherance to the intimation captioned "US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA" dated 23rd August, 2019,...
      Bayer to streamline structure of Management Board to cut costs

      Bayer to streamline structure of Management Board to cut costs

      Medical Dialogues Bureau12 Sept 2019 9:15 AM IST
      Bayer said last year it would lean more strongly on external firms and institutions for a better drug development pipeline, which most analysts regard...
      Purdue Pharma billion dollar OxyContin settlement would rank among largest in pharma history

      Purdue Pharma billion dollar OxyContin settlement would rank among largest in pharma history

      Medical Dialogues Bureau12 Sept 2019 9:00 AM IST
      Purdue Pharma's settlement could be valued at up to $12 billion, they said, which would make it the largest such settlement in U.S. pharmaceutical...
      Glenmark Pharma gets USFDA nod for generic version of Olux-E Foam to treat plaque psoriasis

      Glenmark Pharma gets USFDA nod for generic version of Olux-E Foam to treat plaque psoriasis

      Medical Dialogues Bureau11 Sept 2019 10:00 AM IST
      "Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Clobetasol Propionate...
      We need measures to save jobs in Automotive Sector: Biocon MD Kiran Mazumdar Shaw

      We need measures to save jobs in Automotive Sector: Biocon MD Kiran Mazumdar Shaw

      Medical Dialogues Bureau11 Sept 2019 9:30 AM IST
      "Passenger Vehicle Sales See Worst Ever Monthly Drop Since 1997-98 - we need measures that r not abt saving auto sector but abt saving 50% of...
      Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

      Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

      Medical Dialogues Bureau11 Sept 2019 9:25 AM IST
      Dr Syed Kazmi joins from Novartis Pharmaceuticals Corporation where he was Vice President, Global Head of Business Development & Licensing for...
      Novartis USD 2.1 million Zolgensma Data Issues: CEO Vas Narasimhan pledges to speed data integrity disclosures

      Novartis USD 2.1 million Zolgensma Data Issues: CEO Vas Narasimhan pledges to speed data integrity disclosures

      Medical Dialogues Bureau11 Sept 2019 9:15 AM IST
      In August, Novartis said it knew about discrepancies in data it had submitted to regulators as it sought approval of Zolgensma, but delayed notifying...
      USFDA warns Juul over unproven claims that e-cigarette is safer than smoking

      USFDA warns Juul over unproven claims that e-cigarette is safer than smoking

      Medical Dialogues Bureau11 Sept 2019 9:00 AM IST
      In a sternly worded warning letter, the agency flagged various claims made by Juul representatives, including that its products are "much safer than...
      Sun Pharma arm fully acquires PJSC Biosintez after buying 3.04 pc remaining stake for Rs 6 crore

      Sun Pharma arm fully acquires PJSC Biosintez after buying 3.04 pc remaining stake for Rs 6 crore

      Medical Dialogues Bureau10 Sept 2019 10:00 AM IST
      Cash consideration of Rubles 54,194,628.60 equivalent to USD 815,201.99 (about Rs 6 crore) was paid to shareholders who tendered their respective...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok